马特林通过降低关联RH域交互体表达的调节来促进结直肠癌的亡
Yuan-Chen Zhou1, Qian-Qian Wang1, Ge-Yu-Jia Zhou2
1Graduate School, Peking University China-Japan Friendship School of Clinical Medicine, Beijing 100029, China.
World journal of gastrointestinal oncology
|December 16, 2024
概括
马特林是一种天然化合物,通过减少SHARPIN,一种抗亡蛋白质,对抗结肠直肠癌 (CRC). 这项研究确定了SHARPIN作为CRC治疗的关键目标,为患者提供了新的希望.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 结肠直肠癌 (CRC) 在中国的5年生存率很低,需要新的治疗药物.
- 马特林通过诱导亡来表现出抗瘤特性,但其在CRC中的机制尚不清楚.
- 了解母体对抗亡蛋白的调节对CRC治疗至关重要.
研究的目的:
- 用蛋白质学来识别涉及结直肠癌的关键亡蛋白质.
- 研究母蛋白在调节这些蛋白质中的作用及其对CRC亡的作用.
- 探索 SHARPIN 作为结直肠癌的潜在治疗点.
主要方法:
- 来自52名CRC患者的瘤和相邻正常组织的蛋白质组分析.
- 使用IHC染色,识别和验证差异表达的亡蛋白,包括SHARPIN.
- 在体外分析马特林对CRC细胞亡,增殖,入侵和迁移的影响.
主要成果:
- 确定了88种抗亡蛋白质;SHARPIN与TNM阶段和生存有显著的关联.
- 在CRC组织中的高SHARPIN表达与晚期TNM阶段和更差的预后相关.
- 孕妇治疗抑制了SHARPIN,诱导了亡,并抑制了CRC细胞的增殖,入侵和迁移.
结论:
- SHARPIN是一种在结直肠癌中高调节的抗亡蛋白.
- 通过降低SHARPIN表达的调节,Matrine具有抗癌作用.
- 马特林作为结直肠癌的潜在治疗药物显示出希望.
相关概念视频
01:22MicroRNAs
21.2K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.2K
02:23Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K